Nano-Polymer Stents May Reach U.S. Market By 2007 At Half The Cost Of DES
This article was originally published in The Gray Sheet
Executive Summary
Polyphosphaze non-carbon-based nano-polymers potentially will offer the same anti-restenosis benefits as drug-eluting stents, but cost only slightly more than bare-metal versions, according to Götz Richter, MD/PhD, University of Heidelberg, Germany